Amgen: Pay

Amgen paid its 5 named executives $58.8M in total in FY2025 (Dec). CEO Robert A. Bradway was paid $24.7M of that.

Pay$100 in the stock at the end of FY09 → $238
CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

Robert A. BradwayChief Executive Officer and President
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)
FY2021 (Dec)
FY2012 (Dec)
FY2011 (Dec)
FY2010 (Dec)
8 years
James E. BradnerExecutive Vice President, Research and Development
FY2025 (Dec)
FY2024 (Dec)
2 years
Peter H. GriffithExecutive Vice President and Chief Financial Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)
FY2021 (Dec)
5 years
Murdo GordonExecutive Vice President, Global Commercial Operations
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)
FY2021 (Dec)
5 years
David M. ReeseExecutive Vice President and Chief Technology Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)
FY2021 (Dec)
5 years

CEO pay against the pay peers

In FY2024 (Dec), the median CEO pay of the 9 peers with pay on file was $23.7M. The CEO of Amgen was paid $24.4M, 3% above the median.

  1. 1Eli Lilly & Co
  2. 2Pfizer
  3. 3Amgen
  4. 4Johnson & Johnson
  5. 5Biogen
  6. 6Gilead Sciences
  7. 7Merck & Co.
  8. 8Bristol Myers Squibb
  9. 9AbbVie
  10. 10Regeneron Pharmaceuticals
  11. 11AstraZeneca plcNot disclosed
  12. 12GlaxoSmithKline plcNot disclosed
  13. 13Novartis AGNot disclosed
  14. 14Roche Holding AGNot disclosed
  15. 15Sanofi S.A.Not disclosed

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.